Your browser doesn't support javascript.
loading
Therapeutic Targets of Probiotics in Parkinson Disease: A Systematic Review of Randomized Controlled Trials.
Atak, Elif Sina; Yildiz, Dilara; Kocatürk, Rümeysa Rabia; Temizyürek, Arzu; Özcan, Öznur Özge; Ergüzel, Türker Tekin; Karahan, Mesut; Tarhan, Nevzat.
Afiliación
  • Atak ES; Department of Nutrition and Dietetics, Faculty of Health Sciences, Üsküdar University, Istanbul, Turkey.
  • Yildiz D; Department of Nutrition and Dietetics, Faculty of Health Sciences, Üsküdar University, Istanbul, Turkey.
  • Kocatürk RR; Department of Nutrition and Dietetics, Faculty of Health Sciences, Üsküdar University, Istanbul, Turkey.
  • Temizyürek A; Department of Physiology, School of Medicine, Koç University, Istanbul, Turkey.
  • Özcan ÖÖ; Department of Molecular Neuroscience, Health Sciences Institute, Üsküdar University, Istanbul, Turkey.
  • Ergüzel TT; Department of Software Engineering, Faculty of Engineering and Natural Sciences, Üsküdar University, Istanbul, Turkey.
  • Karahan M; Department of Nutrition and Dietetics, Faculty of Health Sciences, Üsküdar University, Istanbul, Turkey.
  • Tarhan N; Department of Biomedical Device Technology, Vocational School of Health Sciences, Üsküdar University, Istanbul, Turkey.
Basic Clin Neurosci ; 15(2): 165-174, 2024.
Article en En | MEDLINE | ID: mdl-39228448
ABSTRACT

Introduction:

Parkinson disease is the world's second most prevalent neurological disease. In this disease, intracytoplasmic neuronal inclusions are observed in enteric neurons in the gastrointestinal tract, and the composition of the intestinal microbiome is altered. These changes correlate with the motor phenotype. A systematic review was conducted to determine the effect of using probiotics in Parkinson disease.

Methods:

Scopus, PubMed, Web of Science, the Cochrane Library, ScienceDirect, and Ovid-LWW were searched until April 2021. A total of 27395 records were found according to inclusion and exclusion criteria with the following

outcomes:

Parkinson disease rating, oxidative stress, and gastrointestinal system markers. Data search, article selection, and data extraction assessments were performed according to the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. The Jadad scale was used to rate the evidence's quality.

Results:

Our study information was gathered from 5 randomized controlled trials involving 350 individuals with Parkinson disease receiving probiotic supplements. Parkinson disease rating and non-motor symptoms test were performed in the samples. Also, oxidative stress (glutathione, malondialdehyde) and gastrointestinal system symptoms (bowel opening frequency, gut transit time, complete bowel movement, spontaneous bowel movements) were evaluated during 4-12 weeks of using probiotics in these patients.

Conclusion:

While all high-quality studies demonstrate improvement in disease symptoms of the patients, currently sufficient data are not available to recommend the use of probiotics for people with Parkinson disease in clinical practice.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Basic Clin Neurosci Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Basic Clin Neurosci Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Irán